{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":36,"total_is_capped":false,"direct_labels_cover":0,"predictions_cover":36,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12","author_layer_release":"2026-06-26"},"query_hash":"4d53a0d75cf7","filters":{"venue":"Drug Resistance Updates"}},"results":[{"id":"W2171452890","doi":"10.1054/drup.2000.0152","title":"Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and impact on treatment","year":2000,"lang":"en","type":"article","venue":"Drug Resistance Updates","topic":"Antibiotic Resistance in Bacteria","field":"Biochemistry, Genetics and Molecular Biology","cited_by":519,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia","funders":"","keywords":"Pseudomonas aeruginosa; Antibiotics; Efflux; Antibiotic resistance; Microbiology; Periplasmic space; Biology; Resistance (ecology); Bacterial outer membrane; Bacteria; Genetics; Gene; Ecology; Escherichia coli","authors":[{"name":"Robert E. W. Hancock","is_ca":true},{"name":"David P. Speert","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.00525736061795576,"gpt":0.2436045997669158,"spread":0.2383472391489601,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003551,0.0005051767,0.0009472932,0.001125679,0.0002979267,0.00222787,0.0006494781,0.001987573,0.003313493],"category_scores_gemma":[0.004649003,0.0002291848,0.0004756797,0.0009582196,0.0006797558,0.002618463,0.0005794032,0.002206633,0.0008413747],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001044749,"about_ca_system_score_gemma":0.001272402,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00104827,"about_ca_topic_score_gemma":0.002299797,"domain_scores_codex":[0.998964,0.0003136511,0.0001341072,0.00008722512,0.0004051259,0.00009597417],"domain_scores_gemma":[0.9956076,0.001907722,0.0004319678,0.0001473103,0.0015258,0.0003796145],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0006987793,0.0003157429,0.002991846,0.002476875,0.0000584777,0.0002705851,0.0002001732,0.0003718598,0.008001912,0.00469892,0.04444148,0.9354733],"study_design_scores_gemma":[0.0001295518,0.001617825,0.01660901,0.00203425,0.0002435837,0.001962998,0.0004409801,0.0008054809,0.005309729,0.004518048,0.9662662,0.00006231303],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.01048062,0.9191602,0.002021518,0.05606996,0.003661152,0.00002766876,0.0001111902,0.000127223,0.008340415],"genre_scores_gemma":[0.05035857,0.9220011,0.003632995,0.01005193,0.00804531,0.00003483006,0.0001689901,0.00003716289,0.005669032],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.003551,"threshold_uncertainty_score":0.01877975,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2123781894","doi":"10.1016/j.drup.2007.01.003","title":"Cell survival, cell death and cell cycle pathways are interconnected: Implications for cancer therapy","year":2007,"lang":"en","type":"review","venue":"Drug Resistance Updates","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":452,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Manitoba; CancerCare Manitoba","funders":"Canadian Institutes of Health Research; CancerCare Manitoba Foundation; Manitoba Medical Service Foundation; Manitoba Health Research Council","keywords":"Cell cycle; Programmed cell death; Context (archaeology); Cell biology; Cyclin-dependent kinase; Biology; Cell growth; Apoptosis; Cancer research; Protein kinase B; Regulator; PI3K/AKT/mTOR pathway; Signal transduction; Genetics; Gene","authors":[{"name":"Subbareddy Maddika","is_ca":true},{"name":"Sudharsana Rao Ande","is_ca":true},{"name":"Soumya Panigrahi","is_ca":true},{"name":"Ted Paranjothy","is_ca":true},{"name":"Kazimierz Węglarczyk","is_ca":true},{"name":"Anne Zuse","is_ca":true},{"name":"Mohsen Eshraghi","is_ca":true},{"name":"Kailash Manda","is_ca":true},{"name":"Emilia Wiecheć","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05591776088849937,"gpt":0.3349819565211766,"spread":0.2790641956326773,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008901313,0.001013415,0.001885355,0.001180791,0.0003756298,0.001524186,0.001113761,0.001616486,0.003265762],"category_scores_gemma":[0.000645801,0.0003283388,0.0004836676,0.00182573,0.0007642764,0.002190221,0.0006986714,0.003562649,0.002086741],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008761249,"about_ca_system_score_gemma":0.001072596,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007962179,"about_ca_topic_score_gemma":0.002620029,"domain_scores_codex":[0.9998009,0.00003914656,0.00002401756,0.00003364939,0.00008027283,0.00002190259],"domain_scores_gemma":[0.9996364,0.0001712671,0.00003660926,0.000009519016,0.000115128,0.00003104328],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001357711,0.000112005,0.0002033034,0.008010476,0.00008404031,0.000297493,0.00006623732,0.0005412424,0.004514114,0.009844949,0.07541326,0.900777],"study_design_scores_gemma":[0.00004015545,0.00008475153,0.0005218821,0.001241874,0.00008978237,0.0008299716,0.00007951963,0.0001749243,0.0005298332,0.004177838,0.9922123,0.0000172967],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001351046,0.99603,0.0003503562,0.001447654,0.0006342767,0.000004972105,0.00001367451,0.00001377507,0.001370157],"genre_scores_gemma":[0.0006170478,0.996015,0.0007505644,0.0008461326,0.000587277,0.00001099491,0.00002767606,0.000002113852,0.001143178],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.003265762,"threshold_uncertainty_score":0.01092505,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2068541511","doi":"10.1016/j.drup.2004.07.002","title":"Leishmaniasis: drugs in the clinic, resistance and new developments","year":2004,"lang":"en","type":"review","venue":"Drug Resistance Updates","topic":"Research on Leishmaniasis Studies","field":"Medicine","cited_by":403,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Centre hospitalier de l'Université Laval","funders":"Centers for Disease Control and Prevention","keywords":"Miltefosine; Pentamidine; Leishmaniasis; Leishmania; Medicine; Antifungal drugs; Amphotericin B; Drug resistance; Antifungal; Pharmacology; Fluconazole; Intensive care medicine; Immunology; Visceral leishmaniasis; Biology; Dermatology; Internal medicine; Microbiology; Pneumonia; Parasite hosting; Computer science","authors":[{"name":"Marc Ouellette","is_ca":true},{"name":"Jolyne Drummelsmith","is_ca":true},{"name":"Barbara Papadopoulou","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.06026731808428146,"gpt":0.3660137248391854,"spread":0.3057464067549039,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001141638,0.001033623,0.002495355,0.003180717,0.0003155091,0.001717335,0.001014661,0.001702565,0.00493014],"category_scores_gemma":[0.001288052,0.0003871521,0.0004898081,0.004229263,0.000682064,0.002272164,0.0006526517,0.002068999,0.002372372],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009567924,"about_ca_system_score_gemma":0.001619097,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001893562,"about_ca_topic_score_gemma":0.005113387,"domain_scores_codex":[0.9996475,0.00007516918,0.00005716956,0.00005815885,0.0001343056,0.00002766638],"domain_scores_gemma":[0.9991546,0.0004041988,0.0001206091,0.00002626417,0.0002205999,0.00007376492],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001700638,0.00009051638,0.0001673694,0.01521046,0.00007003241,0.0002349776,0.00005896814,0.0002424341,0.001651501,0.001867114,0.0438326,0.9364039],"study_design_scores_gemma":[0.00004550366,0.0001283986,0.0006767284,0.003174607,0.0001316646,0.001225736,0.00007353348,0.00007542229,0.0002887556,0.000841624,0.993323,0.00001492895],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0000598375,0.9988686,0.00005335316,0.0003163677,0.000194209,0.000002503964,0.000008427787,0.000005975193,0.0004907402],"genre_scores_gemma":[0.0003122466,0.9985714,0.0001332427,0.0002549304,0.0002377498,0.000002836427,0.00001345702,9.253867e-7,0.0004731839],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.00493014,"threshold_uncertainty_score":0.01649296,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2114168745","doi":"10.1016/j.drup.2015.08.001","title":"International expert opinion on the management of infection caused by azole-resistant Aspergillus fumigatus","year":2015,"lang":"en","type":"article","venue":"Drug Resistance Updates","topic":"Antifungal resistance and susceptibility","field":"Medicine","cited_by":330,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University","funders":"Sanofi Pasteur; Astellas Foundation for Research on Metabolic Disorders; Astellas Pharma; Bundesministerium für Bildung und Forschung; Cidara Therapeutics; National Institute of Allergy and Infectious Diseases; Medical Research Council; Celgene; Pfizer; Dainippon Sumitomo Pharma; Janssen Pharmaceuticals; Gilead Sciences; Radboud Universiteit; Sanofi; European Commission; Viropharma; Bristol-Myers Squibb","keywords":"Azole; Voriconazole; Micafungin; Aspergillosis; Aspergillus fumigatus; Itraconazole; Echinocandin; Medicine; Intensive care medicine; Drug resistance; Aspergillus; Amphotericin B; Esophageal candidiasis; Microbiology; Biology; Antifungal; Immunology; Fluconazole; Dermatology","authors":[{"name":"Paul E. Verweij","is_ca":false},{"name":"Michelle Ananda‐Rajah","is_ca":false},{"name":"David R. Andes","is_ca":false},{"name":"Maiken Cavling Arendrup","is_ca":false},{"name":"Roger J. M. Brüggemann","is_ca":false},{"name":"Anuradha Chowdhary","is_ca":false},{"name":"Oliver A. Cornely","is_ca":false},{"name":"David W. Denning","is_ca":false},{"name":"Andreas H. Groll","is_ca":false},{"name":"Koichi Izumikawa","is_ca":false},{"name":"Bart Jan Kullberg","is_ca":false},{"name":"Katrien Lagrou","is_ca":false},{"name":"Johan Maertens","is_ca":false},{"name":"Jacques F. Meis","is_ca":false},{"name":"Pippa Newton","is_ca":false},{"name":"Iain Page","is_ca":false},{"name":"Seyedmojtaba Seyedmousavi","is_ca":false},{"name":"Donald C. Sheppard","is_ca":true},{"name":"Claudio Viscoli","is_ca":false},{"name":"Adilia Warris","is_ca":false},{"name":"J. Peter Donnelly","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02548187277548414,"gpt":0.295827424816365,"spread":0.2703455520408809,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003375113,0.000736796,0.001046129,0.00139819,0.0005339205,0.001896686,0.001749605,0.005394685,0.01286004],"category_scores_gemma":[0.01198196,0.0002990413,0.001198521,0.0008941265,0.0006150546,0.001530342,0.0008375476,0.004074303,0.007728419],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001545516,"about_ca_system_score_gemma":0.002116895,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001905551,"about_ca_topic_score_gemma":0.002712207,"domain_scores_codex":[0.9975812,0.0008098764,0.0003899835,0.0001941291,0.0007977,0.0002270281],"domain_scores_gemma":[0.9914654,0.00188925,0.000924086,0.0001152004,0.004836335,0.0007697404],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00005313105,0.00002958176,0.000214872,0.001933038,0.00002768553,0.0005085478,0.00006767148,0.000113819,0.0003367948,0.0008628077,0.8195072,0.1763449],"study_design_scores_gemma":[0.00002509583,0.00002324046,0.0003998012,0.003087041,0.00004361308,0.0009473476,0.00004846759,0.0001037431,0.0001096675,0.0008182051,0.9943825,0.00001118349],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001371018,0.4171676,0.003924535,0.3314315,0.1634022,0.0003452273,0.001043559,0.0002617212,0.08105271],"genre_scores_gemma":[0.02531547,0.5409498,0.009554314,0.1912163,0.1755976,0.0006242188,0.003335937,0.0001459057,0.0532604],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.01286004,"threshold_uncertainty_score":0.04302108,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2087950464","doi":"10.1016/s1368-7646(02)00021-3","title":"Resistance of herpesviruses to antiviral drugs: clinical impacts and molecular mechanisms","year":2002,"lang":"en","type":"review","venue":"Drug Resistance Updates","topic":"Herpesvirus Infections and Treatments","field":"Medicine","cited_by":324,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Centre hospitalier universitaire de Québec; Université Laval","funders":"","keywords":"Ganciclovir; Foscarnet; Virology; Famciclovir; Herpes simplex virus; Cidofovir; Biology; Thymidine kinase; Valaciclovir; Herpesviridae; Antiviral drug; Drug resistance; Human cytomegalovirus; Nucleoside analogue; DNA polymerase; Cytomegalovirus; Virus; Polymerase; Nucleoside; Viral disease; DNA; Microbiology; Genetics","authors":[{"name":"Christian Gilbert","is_ca":true},{"name":"Julie Bestman‐Smith","is_ca":true},{"name":"Guy Boivin","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03304748137064542,"gpt":0.3666449093710895,"spread":0.3335974280004441,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008695749,0.000785728,0.001749247,0.001643211,0.000232737,0.001142993,0.000887098,0.001199415,0.00289546],"category_scores_gemma":[0.0009659358,0.0002411857,0.0004332258,0.001735166,0.0003882071,0.001395436,0.0003653122,0.001348636,0.001383122],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004828362,"about_ca_system_score_gemma":0.0007475402,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007768773,"about_ca_topic_score_gemma":0.001482058,"domain_scores_codex":[0.9997725,0.00004432306,0.00003894051,0.00003601622,0.00008899141,0.00001921939],"domain_scores_gemma":[0.9994022,0.0003435959,0.0000717874,0.00001587232,0.0001350576,0.00003148166],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00014084,0.0000694337,0.0002561758,0.005707258,0.0000523276,0.0003130824,0.00004240634,0.0001783521,0.00240942,0.001095482,0.01425378,0.9754815],"study_design_scores_gemma":[0.0000620635,0.0002596836,0.001660438,0.001876784,0.0002339629,0.003981634,0.00009197231,0.0001443661,0.001708395,0.001160086,0.988799,0.00002152665],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0002478167,0.9981107,0.0002023726,0.000269169,0.0002255211,0.000004752069,0.00001126971,0.000008336451,0.0009201687],"genre_scores_gemma":[0.001029621,0.9971456,0.0003758032,0.0002603705,0.0003544498,0.000006725986,0.00002658242,0.000001359037,0.0007993703],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.00289546,"threshold_uncertainty_score":0.009686351,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4200113990","doi":"10.1016/j.drup.2021.100794","title":"An update on drugs with therapeutic potential for SARS-CoV-2 (COVID-19) treatment","year":2021,"lang":"en","type":"review","venue":"Drug Resistance Updates","topic":"COVID-19 Clinical Research Studies","field":"Medicine","cited_by":292,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"CancerCare Manitoba; Children's Hospital Research Institute of Manitoba; University of Manitoba; Research Institute in Oncology and Hematology","funders":"Silesian University of Technology","keywords":"Medicine; Hydroxychloroquine; Pandemic; Lopinavir; Coronavirus disease 2019 (COVID-19); Ribavirin; Intensive care medicine; Ritonavir; Interim analysis; Clinical endpoint; Randomized controlled trial; Interim; Disease; Internal medicine; Viral load; Virology; Virus; Infectious disease (medical specialty)","authors":[{"name":"Sylwester Drożdżal","is_ca":false},{"name":"Jakub Rosik","is_ca":false},{"name":"Kacper Lechowicz","is_ca":false},{"name":"Filip Machaj","is_ca":false},{"name":"Bartosz Szostak","is_ca":false},{"name":"Jarosław Przybyciński","is_ca":false},{"name":"Shahrokh Lorzadeh","is_ca":false},{"name":"Katarzyna Kotfis","is_ca":false},{"name":"Saeid Ghavami","is_ca":true},{"name":"Marek Łoś","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.113283966716191,"gpt":0.4875776992917716,"spread":0.3742937325755806,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001723889,0.0009781115,0.002262451,0.003171511,0.0002193563,0.001585304,0.0008319538,0.001427754,0.00804248],"category_scores_gemma":[0.002845225,0.0003942126,0.001515595,0.002423753,0.0003673779,0.001571709,0.0009197083,0.002214683,0.001829289],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000904311,"about_ca_system_score_gemma":0.002610498,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001494218,"about_ca_topic_score_gemma":0.004402156,"domain_scores_codex":[0.9995459,0.0001144795,0.0001201592,0.00004305434,0.0001292274,0.00004713349],"domain_scores_gemma":[0.998621,0.0007093749,0.0002791424,0.00002717676,0.0002800461,0.00008336233],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002947075,0.00007992246,0.0001521686,0.04719429,0.0003206572,0.000135675,0.00004596443,0.000268177,0.001115731,0.001401632,0.08114784,0.8678433],"study_design_scores_gemma":[0.0002685291,0.0003699882,0.0009072638,0.02417869,0.001534313,0.0005204885,0.0000451053,0.0001519229,0.000386834,0.000944127,0.9706644,0.00002827354],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001081681,0.9975448,0.00009111559,0.0006418053,0.0004346817,0.00001923506,0.0001291027,0.00001653101,0.001014529],"genre_scores_gemma":[0.0006458965,0.9970807,0.0002919032,0.001078176,0.000290902,0.00001913679,0.0001457875,0.000002901358,0.000444567],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.00804248,"threshold_uncertainty_score":0.02690476,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2040642086","doi":"10.1016/j.drup.2012.06.001","title":"Insights into the global molecular epidemiology of carbapenem non-susceptible clones of Acinetobacter baumannii","year":2012,"lang":"en","type":"review","venue":"Drug Resistance Updates","topic":"Antibiotic Resistance in Bacteria","field":"Biochemistry, Genetics and Molecular Biology","cited_by":262,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Queen's University","funders":"","keywords":"Acinetobacter baumannii; Multilocus sequence typing; Biology; Microbiology; Antibiotics; Molecular epidemiology; Antibiotic resistance; Carbapenem; Outbreak; Population; Multiple drug resistance; Typing; Genetics; Virology; Gene; Medicine; Bacteria; Genotype; Pseudomonas aeruginosa; Environmental health","authors":[{"name":"Nabil Karah","is_ca":false},{"name":"Arnfinn Sundsfjord","is_ca":false},{"name":"K. J. Towner","is_ca":true},{"name":"Ørjan Samuelsen","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01943733421591278,"gpt":0.3102078049370245,"spread":0.2907704707211118,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007487066,0.0007477083,0.001133729,0.001678033,0.0001766774,0.001115307,0.0007255414,0.001011822,0.002101462],"category_scores_gemma":[0.001343622,0.0002415728,0.0003485724,0.001844884,0.0004213676,0.001306011,0.0005560936,0.00117414,0.0009938816],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00071864,"about_ca_system_score_gemma":0.001426458,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002007763,"about_ca_topic_score_gemma":0.003611553,"domain_scores_codex":[0.9997687,0.00003608904,0.00003277881,0.00004856144,0.00009099219,0.00002296158],"domain_scores_gemma":[0.9993528,0.0002553163,0.0001054904,0.00001655033,0.0002175442,0.00005236839],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00006900976,0.00003014485,0.0003542424,0.009637953,0.00005177926,0.0001182872,0.00003208095,0.0001935441,0.001562897,0.001222881,0.02538508,0.9613422],"study_design_scores_gemma":[0.00001675582,0.00009540887,0.002484465,0.003677249,0.0001883562,0.001229898,0.00008167932,0.0001287167,0.0008437134,0.001099511,0.9901294,0.00002482493],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001300301,0.9988899,0.0001095003,0.0003096761,0.0001514319,0.000001878669,0.00002283943,0.000004913191,0.0003798174],"genre_scores_gemma":[0.0005552441,0.9985935,0.0002040315,0.0001696757,0.0001672163,0.000002146701,0.00003305878,0.00000102894,0.000274056],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.002101462,"threshold_uncertainty_score":0.00703007,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2029697713","doi":"10.1016/j.drup.2008.08.005","title":"SPARC in cancer biology: Its role in cancer progression and potential for therapy","year":2008,"lang":"en","type":"review","venue":"Drug Resistance Updates","topic":"Bone and Dental Protein Studies","field":"Medicine","cited_by":240,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"Matricellular protein; Cancer; Colorectal cancer; Cancer research; Biology; Tumor progression; Ovarian cancer; Cancer cell; Phenotype; Medicine; Extracellular matrix; Genetics; Gene","authors":[{"name":"Isabella T. Tai","is_ca":true},{"name":"Michelle Tang","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04108337212371253,"gpt":0.3901327339218124,"spread":0.3490493617980998,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009636281,0.0008213323,0.001643289,0.001687678,0.0002193935,0.001032355,0.0007112185,0.001074234,0.002782348],"category_scores_gemma":[0.0008154658,0.000236793,0.000414197,0.002168307,0.0006267232,0.001334923,0.0005757196,0.00180764,0.001666161],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006280617,"about_ca_system_score_gemma":0.001123761,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001159485,"about_ca_topic_score_gemma":0.002947104,"domain_scores_codex":[0.99983,0.00002666369,0.00002435818,0.00002714709,0.0000757803,0.00001600826],"domain_scores_gemma":[0.999626,0.0001790373,0.00004520822,0.00001148647,0.0001050885,0.00003309052],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001439686,0.00006917997,0.0002287369,0.008141609,0.00008134441,0.0002246165,0.0000339857,0.0002883203,0.002973679,0.002318572,0.04047292,0.9450231],"study_design_scores_gemma":[0.00004445238,0.0001402702,0.0008085985,0.001508509,0.0001571494,0.001294898,0.00005475354,0.00012721,0.001111188,0.001333126,0.9934056,0.00001425059],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001812519,0.9978818,0.0001643574,0.0005348873,0.0003099939,0.000003686745,0.00001885695,0.000007382142,0.0008976577],"genre_scores_gemma":[0.0007573774,0.9970794,0.0003549316,0.0004044368,0.0003311821,0.000005426335,0.00003181521,0.000001666915,0.001033782],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.002782348,"threshold_uncertainty_score":0.009307861,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4387731505","doi":"10.1016/j.drup.2023.101012","title":"Antibiotic failure: Beyond antimicrobial resistance","year":2023,"lang":"en","type":"review","venue":"Drug Resistance Updates","topic":"Antibiotic Resistance in Bacteria","field":"Biochemistry, Genetics and Molecular Biology","cited_by":228,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia","funders":"Canadian Institutes of Health Research; Perelman School of Medicine, University of Pennsylvania; Defense Threat Reduction Agency; Killam Trusts; Brain and Behavior Research Foundation; National Institute of General Medical Sciences; United Therapeutics Corporation; International Association for Dental Research; University of British Columbia; University of Pennsylvania; National Institutes of Health; ACE Foundation; Procter and Gamble","keywords":"Antibiotic resistance; Antibiotics; Intensive care medicine; Medicine; Sepsis; Antimicrobial; Microbiome; Biology; Microbiology; Immunology; Bioinformatics","authors":[{"name":"César de la Fuente‐Núñez","is_ca":false},{"name":"Angela Cesaro","is_ca":false},{"name":"Robert E. W. Hancock","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01472030605848085,"gpt":0.2833561460175726,"spread":0.2686358399590917,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00116686,0.001315957,0.00254209,0.001889278,0.0002806891,0.001773414,0.001146959,0.002188704,0.004903125],"category_scores_gemma":[0.002279021,0.0002532332,0.0006550908,0.001662909,0.0008691624,0.001850569,0.001060156,0.004106201,0.00269094],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009470048,"about_ca_system_score_gemma":0.001516547,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001078833,"about_ca_topic_score_gemma":0.002657771,"domain_scores_codex":[0.9995241,0.0001224814,0.00005757172,0.0000693871,0.0001818331,0.00004470881],"domain_scores_gemma":[0.9987577,0.0006731896,0.0001297626,0.00003320907,0.0002711367,0.0001350239],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00009438113,0.00004604092,0.0001317854,0.00922975,0.00007451295,0.0001728361,0.00002970568,0.0002808852,0.0006023827,0.0040889,0.1128411,0.8724077],"study_design_scores_gemma":[0.0000357787,0.00007954548,0.0004332167,0.005035022,0.0001056886,0.0008252066,0.00004535793,0.0001480436,0.0001329835,0.002888537,0.9902533,0.00001726917],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00002606492,0.9978624,0.0001247973,0.0007657831,0.0006902777,0.000001963475,0.000009837976,0.000009170421,0.0005096239],"genre_scores_gemma":[0.0003108074,0.9963671,0.0001945218,0.001150727,0.001357823,0.000004483863,0.00002760959,0.000003261579,0.0005835928],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.004903125,"threshold_uncertainty_score":0.0164026,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2092643107","doi":"10.1016/j.drup.2011.01.001","title":"Creeping baselines and adaptive resistance to antibiotics","year":2011,"lang":"en","type":"review","venue":"Drug Resistance Updates","topic":"Antibiotic Resistance in Bacteria","field":"Biochemistry, Genetics and Molecular Biology","cited_by":228,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia","funders":"","keywords":"Antibiotic resistance; Resistance (ecology); Adaptive response; Adaptation (eye); Biology; Antibiotics; Mechanism (biology); Drug resistance; Intensive care medicine; Evolutionary biology; Biotechnology; Genetics; Medicine; Ecology; Neuroscience","authors":[{"name":"Lucía Fernández","is_ca":true},{"name":"Elena B. M. Breidenstein","is_ca":true},{"name":"Robert E. W. Hancock","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02539359851969317,"gpt":0.2899207888008317,"spread":0.2645271902811385,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009248618,0.001066854,0.00179142,0.001747754,0.0003415108,0.001641902,0.001179783,0.002295909,0.00282892],"category_scores_gemma":[0.001693382,0.000427796,0.000381045,0.001934821,0.001259358,0.002524201,0.0009163202,0.002863388,0.00195681],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001027453,"about_ca_system_score_gemma":0.001081655,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001200555,"about_ca_topic_score_gemma":0.002281765,"domain_scores_codex":[0.999702,0.00005321309,0.00003792443,0.00005488173,0.000121734,0.00003022948],"domain_scores_gemma":[0.9993635,0.0003203988,0.00008084096,0.00002208556,0.0001626506,0.00005050539],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0000920272,0.00005230651,0.0001727703,0.007731905,0.00004038408,0.0001905484,0.00005755846,0.0003748882,0.002193766,0.007260025,0.06010444,0.9217293],"study_design_scores_gemma":[0.00001395092,0.00003966856,0.0003930985,0.001409221,0.00004731659,0.0008526803,0.00005135632,0.0001085771,0.000431541,0.003486754,0.9931504,0.00001550477],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00008039686,0.9980526,0.0002051719,0.0005861236,0.0004357148,0.000002478018,0.00001084239,0.00000826873,0.0006183529],"genre_scores_gemma":[0.0005375241,0.9974782,0.0002410371,0.0004255981,0.0005986826,0.000004200773,0.00002065302,0.000002230705,0.0006919443],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.00282892,"threshold_uncertainty_score":0.009463727,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2794341756","doi":"10.1016/j.drup.2018.01.004","title":"Hepatitis C virus drug resistance associated substitutions and their clinical relevance: Update 2018","year":2018,"lang":"en","type":"review","venue":"Drug Resistance Updates","topic":"Hepatitis C virus research","field":"Medicine","cited_by":196,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"St. Paul's Hospital","funders":"","keywords":"NS5A; Hepatitis C virus; NS5B; NS3; Medicine; Virology; Drug resistance; Hepacivirus; Virus; Drug development; Drug; Pharmacology; Biology; Genetics","authors":[{"name":"M.C. Sorbo","is_ca":false},{"name":"Valeria Cento","is_ca":false},{"name":"Velia Chiara Di Maio","is_ca":false},{"name":"A Howe","is_ca":true},{"name":"Féderico García","is_ca":false},{"name":"Carlo Federico Perno","is_ca":false},{"name":"Francesca Ceccherini‐Silberstein","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05785593860325694,"gpt":0.3852783326130977,"spread":0.3274223940098408,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001117546,0.0007406404,0.001697824,0.002691387,0.0002012387,0.00160701,0.0008328204,0.001268402,0.006334886],"category_scores_gemma":[0.003307752,0.0002852929,0.001032749,0.002208228,0.0003339391,0.001539635,0.0008428796,0.001700121,0.001361987],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006689643,"about_ca_system_score_gemma":0.002342714,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001289661,"about_ca_topic_score_gemma":0.003926901,"domain_scores_codex":[0.9995413,0.00009444657,0.0001289396,0.00005435862,0.0001387557,0.0000421526],"domain_scores_gemma":[0.9980928,0.0008947498,0.0004070007,0.00003837022,0.0004674267,0.0000995336],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"systematic_review","study_design_scores_codex":[0.0002030694,0.00005854795,0.0005196592,0.03949198,0.0002863547,0.0001913395,0.00006802539,0.0001477842,0.0008575931,0.0009803773,0.0791953,0.878],"study_design_scores_gemma":[0.000101641,0.0001315043,0.001801717,0.01681357,0.001204049,0.001255807,0.00009964563,0.000122323,0.0003452931,0.0007898542,0.9773045,0.00003019571],"study_design_candidate":"systematic_review","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000152742,0.9977103,0.00007700631,0.0006683757,0.0005843511,0.000009897726,0.0001133402,0.00001278615,0.0006711315],"genre_scores_gemma":[0.001151892,0.9959376,0.0003519114,0.001244194,0.0006302868,0.000009747643,0.000175023,0.000003374538,0.0004959715],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.006334886,"threshold_uncertainty_score":0.02119225,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2920869071","doi":"10.1016/j.drup.2018.03.003","title":"Glioblastoma cancer stem cell biology: Potential theranostic targets","year":2019,"lang":"en","type":"review","venue":"Drug Resistance Updates","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":191,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Manitoba; Research Institute in Oncology and Hematology; Children's Hospital Research Institute of Manitoba; Southlake Regional Health Center; CancerCare Manitoba","funders":"HORIZON EUROPE Marie Sklodowska-Curie Actions; Royan Institute","keywords":"Glioblastoma; Stem cell; Cancer stem cell; Biology; Cancer research; Stem cell biology; Brain cancer; Cancer; Computational biology; Medicine; Cell biology; Genetics; Gene","authors":[{"name":"Farzaneh Sharifzad","is_ca":false},{"name":"Saeid Ghavami","is_ca":true},{"name":"Javad Verdi","is_ca":false},{"name":"Soura Mardpour","is_ca":false},{"name":"Mahsa Mollapour Sisakht","is_ca":false},{"name":"Zahra Azizi","is_ca":true},{"name":"Adeleh Taghikhani","is_ca":false},{"name":"Marek Łoś","is_ca":false},{"name":"Esmail Fakharian","is_ca":false},{"name":"Marzieh Ebrahimi","is_ca":false},{"name":"Amir Ali Hamidieh","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02210126948574178,"gpt":0.3150508559541841,"spread":0.2929495864684424,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006172169,0.0008231453,0.001267767,0.001525414,0.0002041309,0.001227097,0.0006295989,0.001105348,0.005136978],"category_scores_gemma":[0.0007499537,0.0002445297,0.0004118572,0.001433061,0.0004294763,0.001223037,0.0007587536,0.002236628,0.002320625],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000683762,"about_ca_system_score_gemma":0.001041645,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009261082,"about_ca_topic_score_gemma":0.003480481,"domain_scores_codex":[0.9998397,0.00002766806,0.00001763795,0.00002487867,0.00006337977,0.00002669598],"domain_scores_gemma":[0.9996846,0.0001357903,0.00003962214,0.000007977368,0.00008937583,0.00004271018],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00009045624,0.0000571528,0.00009994466,0.008711831,0.00004796106,0.0000989935,0.0000277656,0.0002814141,0.001685547,0.003394146,0.07069662,0.9148082],"study_design_scores_gemma":[0.00003034448,0.00009629202,0.0003190471,0.002041376,0.00008560732,0.0003589806,0.00003168985,0.0001227978,0.0003607312,0.001694299,0.9948465,0.00001253662],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00009169563,0.9974222,0.0001331697,0.0006697892,0.0004248795,0.000004637026,0.00003126655,0.00001154924,0.001210798],"genre_scores_gemma":[0.00060148,0.9970932,0.0001978702,0.0006638133,0.0004101526,0.000006728487,0.000052638,0.00000191304,0.0009721783],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.005136978,"threshold_uncertainty_score":0.01718485,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3042832159","doi":"10.1016/j.drup.2020.100719","title":"FDA approved drugs with pharmacotherapeutic potential for SARS-CoV-2 (COVID-19) therapy","year":2020,"lang":"en","type":"review","venue":"Drug Resistance Updates","topic":"COVID-19 Clinical Research Studies","field":"Medicine","cited_by":189,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Manitoba","funders":"","keywords":"Medicine; Lopinavir; Hydroxychloroquine; Favipiravir; Ritonavir; Azithromycin; Clinical trial; Chloroquine; Pharmacology; Intensive care medicine; Virology; Immunology; Disease; Antibiotics; Coronavirus disease 2019 (COVID-19); Malaria; Virus; Internal medicine; Viral load; Biology","authors":[{"name":"Sylwester Drożdżal","is_ca":false},{"name":"Jakub Rosik","is_ca":false},{"name":"Kacper Lechowicz","is_ca":false},{"name":"Filip Machaj","is_ca":false},{"name":"Katarzyna Kotfis","is_ca":false},{"name":"Saeid Ghavami","is_ca":true},{"name":"Marek Łoś","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.12587865412803,"gpt":0.4819622007752686,"spread":0.3560835466472386,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001583313,0.0008702277,0.00188088,0.002000822,0.000235953,0.001396386,0.0009101007,0.001276728,0.0123264],"category_scores_gemma":[0.002020383,0.0003057643,0.00140837,0.001708715,0.0004034287,0.00106249,0.0006953441,0.002239272,0.002742023],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009635602,"about_ca_system_score_gemma":0.00235858,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001732428,"about_ca_topic_score_gemma":0.005626347,"domain_scores_codex":[0.9996879,0.00007257619,0.00005474656,0.00004003641,0.0001009883,0.00004384815],"domain_scores_gemma":[0.9990741,0.0004463631,0.0001822941,0.00002033683,0.0002175479,0.00005922807],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0003975626,0.0001143522,0.0001642854,0.02578168,0.0002614485,0.0001201805,0.00003669655,0.0002627916,0.001551374,0.002226647,0.04487243,0.9242105],"study_design_scores_gemma":[0.0004774956,0.0005811134,0.00106335,0.01554953,0.001127071,0.0005056564,0.00005621797,0.0001624896,0.0006438953,0.001140739,0.9786654,0.0000270167],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0003289312,0.9948217,0.0001940296,0.0008042588,0.0003258424,0.00004583908,0.0002224247,0.00002744992,0.00322946],"genre_scores_gemma":[0.001992213,0.9946229,0.0005252087,0.001232471,0.000170322,0.00003727933,0.0002607899,0.000005051038,0.001153835],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.0123264,"threshold_uncertainty_score":0.04123586,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2767031674","doi":"10.1016/j.drup.2017.10.003","title":"Not only P-glycoprotein: Amplification of the ABCB1- containing chromosome region 7q21 confers multidrug resistance upon cancer cells by coordinated overexpression of an assortment of resistance-related proteins","year":2017,"lang":"en","type":"review","venue":"Drug Resistance Updates","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":170,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Associazione Italiana per la Ricerca sul Cancro; Ministry of Health, British Columbia; Sapienza Università di Roma; Ministero dell’Istruzione, dell’Università e della Ricerca","keywords":"Multiple drug resistance; Biology; Efflux; P-glycoprotein; Cancer cell; Cancer research; Drug resistance; ATP-binding cassette transporter; Epigenetics; Locus (genetics); Vinca; Gene; Cancer; Genetics; Pharmacology; Transporter","authors":[{"name":"Ilaria Genovese","is_ca":false},{"name":"Andrea Ilari","is_ca":false},{"name":"Yehuda G. Assaraf","is_ca":false},{"name":"Francesco Fazi","is_ca":false},{"name":"Gianni Colotti","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03416051113123444,"gpt":0.3147363883626371,"spread":0.2805758772314026,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001413089,0.0003768212,0.0003789134,0.0005846114,0.0002535948,0.0006414745,0.0001742605,0.0005147622,0.003974085],"category_scores_gemma":[0.0003114853,0.0001960164,0.0002550242,0.000569445,0.0002743511,0.0004136456,0.0004028059,0.0006825087,0.001909146],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002946055,"about_ca_system_score_gemma":0.0002274149,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004043172,"about_ca_topic_score_gemma":0.0004903348,"domain_scores_codex":[0.9996837,0.0000374594,0.00002128092,0.0000927474,0.0001322545,0.00003246962],"domain_scores_gemma":[0.9998073,0.00002894515,0.00005006562,0.00002953026,0.00004701633,0.00003725403],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00005812112,0.00002348682,0.002080813,0.00005831961,0.00002215178,0.0005734431,0.0000302311,0.00005793916,0.9874526,0.0002590182,0.0005663264,0.008817584],"study_design_scores_gemma":[0.0000515744,0.000648715,0.1049533,0.00002657018,0.0002034707,0.01726383,0.0001209036,0.001412853,0.8091654,0.001060994,0.06504806,0.00004433953],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"review","genre_scores_codex":[0.9602315,0.01576968,0.008964671,0.002188327,0.0002170533,0.00007616598,0.001664825,0.0005589132,0.01032879],"genre_scores_gemma":[0.979131,0.007765396,0.001810851,0.0003006593,0.0000923425,0.00007282711,0.001885369,0.00008010111,0.008861512],"genre_candidate":"review","genre_consensus":null,"teacher_disagreement_score":0.003974085,"threshold_uncertainty_score":0.01329464,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1964137986","doi":"10.1016/s1368-7646(02)00003-1","title":"Role of X-linked inhibitor of apoptosis protein in chemoresistance in ovarian cancer: possible involvement of the phosphoinositide-3 kinase/Akt pathway","year":2002,"lang":"en","type":"review","venue":"Drug Resistance Updates","topic":"Cell death mechanisms and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":150,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Ottawa; Ottawa Hospital","funders":"National Cancer Institute","keywords":"XIAP; Ovarian cancer; PI3K/AKT/mTOR pathway; Protein kinase B; Cancer research; Cisplatin; Inhibitor of apoptosis; Programmed cell death; Apoptosis; Biology; Kinase; Cancer; Signal transduction; Cancer cell; Cell biology; Caspase; Chemotherapy; Genetics","authors":[{"name":"Jin Q. Cheng","is_ca":false},{"name":"Xiuxian Jiang","is_ca":true},{"name":"Michael Fraser","is_ca":true},{"name":"Ming Li","is_ca":true},{"name":"Han C. Dan","is_ca":false},{"name":"Mei Sun","is_ca":false},{"name":"Benjamin K. Tsang","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.009680834590482428,"gpt":0.2352078145243284,"spread":0.2255269799338459,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005635282,0.0008121541,0.001280391,0.0009613676,0.0002547581,0.000896022,0.0008133205,0.001088861,0.001771936],"category_scores_gemma":[0.0003557848,0.0001788089,0.00032813,0.001159006,0.0003969934,0.0009948981,0.0003319334,0.001476023,0.001900736],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000520208,"about_ca_system_score_gemma":0.0006612203,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000707035,"about_ca_topic_score_gemma":0.001371687,"domain_scores_codex":[0.9998907,0.00001392415,0.00001696677,0.00002367219,0.00004300098,0.00001178639],"domain_scores_gemma":[0.999795,0.00008085875,0.00002700104,0.000006092137,0.00006904583,0.0000219439],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.0002441076,0.0001021867,0.0004896241,0.005111895,0.00008477904,0.0007862963,0.00004158075,0.0003289881,0.007426578,0.002284898,0.03278801,0.9503111],"study_design_scores_gemma":[0.00009999884,0.0003106824,0.002538383,0.0009746766,0.0002143904,0.004866534,0.00007408364,0.0002384635,0.003820042,0.001660523,0.9851727,0.0000294479],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0004321666,0.997211,0.0003519915,0.0003605491,0.0004417637,0.000004725683,0.00001687251,0.00001368263,0.00116715],"genre_scores_gemma":[0.001903549,0.9947526,0.0006100414,0.000379216,0.0003945271,0.000008691734,0.00005181509,0.000002285232,0.001897277],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.001771936,"threshold_uncertainty_score":0.005927682,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2273626774","doi":"10.1016/j.drup.2016.02.001","title":"Could drugs inhibiting the mevalonate pathway also target cancer stem cells?","year":2016,"lang":"en","type":"review","venue":"Drug Resistance Updates","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":88,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Manitoba","funders":"","keywords":"Mevalonate pathway; Cancer; Cancer stem cell; Cancer research; Carcinogenesis; Cancer cell; Metastasis; Hippo signaling pathway; Biology; Signal transduction; Epithelial–mesenchymal transition; Stem cell; Cell biology; Bioinformatics; Reductase; Genetics; Biochemistry; Enzyme","authors":[{"name":"Wirginia Likus","is_ca":false},{"name":"Krzysztof Siemianowicz","is_ca":false},{"name":"Konrad Bieńk","is_ca":false},{"name":"Malgorzata Maria Pakula","is_ca":false},{"name":"Himani Pathak","is_ca":false},{"name":"Chhanda Dutta","is_ca":false},{"name":"Qiong Wang","is_ca":false},{"name":"Shahla Shojaei","is_ca":false},{"name":"Yehuda G. Assaraf","is_ca":false},{"name":"Saeid Ghavami","is_ca":true},{"name":"Artur Cieślar‐Pobuda","is_ca":false},{"name":"Marek Łoś","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01300497741820996,"gpt":0.2755649961688785,"spread":0.2625600187506685,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004337859,0.0005796792,0.001119669,0.000890418,0.000186333,0.0008660195,0.0006830912,0.0009540747,0.004445365],"category_scores_gemma":[0.0005277183,0.0001736786,0.0004509653,0.0007425185,0.0003679531,0.001128328,0.0005043616,0.001905173,0.002011803],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005033648,"about_ca_system_score_gemma":0.0006452934,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006971081,"about_ca_topic_score_gemma":0.002406929,"domain_scores_codex":[0.9998924,0.00001777151,0.00001317096,0.00001804943,0.00004224743,0.00001655512],"domain_scores_gemma":[0.9998448,0.00006456079,0.00002294055,0.000006107193,0.00004315882,0.00001842785],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000183159,0.00006263869,0.0001915507,0.007328808,0.0000913753,0.0002614572,0.00003293881,0.0002487764,0.00411636,0.005231096,0.05833038,0.9239213],"study_design_scores_gemma":[0.00004236171,0.00009775643,0.0003381486,0.001004899,0.0001022805,0.0007621535,0.00002856548,0.00008701945,0.000859008,0.001757502,0.9949078,0.00001249586],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001776992,0.996792,0.0002203795,0.001062204,0.0005322211,0.000005068735,0.00003116814,0.00001650379,0.001162673],"genre_scores_gemma":[0.001317072,0.9957756,0.000275657,0.0007394542,0.0003923577,0.000007705951,0.00006158229,0.000002911602,0.001427573],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.004445365,"threshold_uncertainty_score":0.01487124,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1965156600","doi":"10.1016/j.drup.2011.04.002","title":"The oncogenic PIM kinase family regulates drug resistance through multiple mechanisms","year":2011,"lang":"en","type":"review","venue":"Drug Resistance Updates","topic":"Cancer Mechanisms and Therapy","field":"Medicine","cited_by":68,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University Health Network; University of Toronto; Ontario Institute for Cancer Research","funders":"Government of Ontario","keywords":"Efflux; Kinase; Biology; Cancer research; Pharmacology; Signal transduction; Cancer; Drug resistance; Cell biology; Genetics","authors":[{"name":"Methvin Isaac","is_ca":true},{"name":"Allan Siu","is_ca":true},{"name":"Jan Jongstra","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03263143506265965,"gpt":0.2976015274292069,"spread":0.2649700923665473,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004945599,0.0008715562,0.001256563,0.001231799,0.0002054262,0.0009788241,0.0006515259,0.0007506215,0.002426059],"category_scores_gemma":[0.0004482628,0.000227282,0.0003429473,0.001286909,0.0004067204,0.001051765,0.0006133415,0.002097776,0.001654128],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006189151,"about_ca_system_score_gemma":0.000707495,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005469892,"about_ca_topic_score_gemma":0.001446518,"domain_scores_codex":[0.9998506,0.00001986333,0.00001694511,0.00002300669,0.00007341221,0.00001615133],"domain_scores_gemma":[0.9998206,0.0000727786,0.00003087455,0.000006010553,0.0000501678,0.00001958695],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00008616117,0.00005278024,0.0001510661,0.005006984,0.00005678609,0.0001649467,0.00002220427,0.0002783389,0.004078911,0.002544249,0.02897899,0.9585785],"study_design_scores_gemma":[0.00004016275,0.00007978478,0.0008539599,0.001149216,0.000127625,0.001146754,0.00003413184,0.0001916917,0.001646457,0.001824479,0.9928866,0.00001910912],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0002392339,0.9964998,0.0003042372,0.0005670016,0.000277059,0.00000595567,0.00002393299,0.00001603665,0.002066828],"genre_scores_gemma":[0.001083003,0.996717,0.0003735007,0.0003139435,0.0002724632,0.000006962224,0.00004369633,0.000001670822,0.001187735],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.002426059,"threshold_uncertainty_score":0.008115947,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2156149052","doi":"10.1016/j.drup.2006.08.001","title":"Methods and biomarkers for the diagnosis and prognosis of cancer and other diseases: Towards personalized medicine","year":2006,"lang":"en","type":"review","venue":"Drug Resistance Updates","topic":"Cytomegalovirus and herpesvirus research","field":"Medicine","cited_by":67,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"CancerCare Manitoba; University of Manitoba; Children's Hospital Research Institute of Manitoba","funders":"Canadian Space Agency; CancerCare Manitoba Foundation; Muscular Dystrophy Association; Manitoba Health Research Council; Manitoba Medical Service Foundation; Health Sciences Centre Foundation; Parent Project Muscular Dystrophy","keywords":"Personalized medicine; Cancer; Computational biology; Bioinformatics; Biology; Medicine; Genetics","authors":[{"name":"Judy E. Anderson","is_ca":true},{"name":"Lise Lotte Hansen","is_ca":false},{"name":"Frank C. Mooren","is_ca":false},{"name":"Markus Post","is_ca":false},{"name":"Hubert Hug","is_ca":false},{"name":"Anne Zuse","is_ca":true},{"name":"Marek Łoś","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.080257720066636,"gpt":0.4580474344439079,"spread":0.3777897143772719,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003863733,0.001295111,0.003788633,0.00360701,0.0002838568,0.001893816,0.001636875,0.002150566,0.002433763],"category_scores_gemma":[0.003172212,0.0005223278,0.0009072713,0.002969997,0.001250396,0.002680295,0.0008545382,0.003599782,0.001799106],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001206347,"about_ca_system_score_gemma":0.001759661,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00142715,"about_ca_topic_score_gemma":0.002099754,"domain_scores_codex":[0.9989543,0.0003029146,0.0001348042,0.0001407991,0.0004267101,0.00004050043],"domain_scores_gemma":[0.9966081,0.002247038,0.0002561534,0.000108341,0.000670329,0.0001100914],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00009316007,0.00009646348,0.0006394265,0.006584754,0.0001622597,0.0001709851,0.00004617995,0.0003778554,0.001644638,0.004680203,0.01854704,0.9669571],"study_design_scores_gemma":[0.00006725302,0.000186682,0.002530538,0.003522362,0.0002862873,0.001793435,0.0001142967,0.0004356066,0.001526677,0.009153225,0.9803277,0.00005587021],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00008465041,0.997016,0.0009397662,0.001051126,0.0003977642,0.000006845873,0.00001773787,0.0000115063,0.0004745274],"genre_scores_gemma":[0.000859506,0.99498,0.001990148,0.0007498883,0.0007608497,0.00001351324,0.00004124791,0.000002483525,0.0006023608],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.003863733,"threshold_uncertainty_score":0.02043366,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4211153257","doi":"10.1016/j.drup.2003.10.002","title":"DNA methylation and cancer therapy","year":2003,"lang":"en","type":"review","venue":"Drug Resistance Updates","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":66,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University","funders":"","keywords":"DNA methylation; CpG site; Methylation; Biology; DNA methyltransferase; Epigenomics; RNA-Directed DNA Methylation; Methyltransferase; DNA; Illumina Methylation Assay; Epigenetics of physical exercise; Epigenetics; Cancer epigenetics; Cancer research; Genetics; Molecular biology; Gene; Gene expression","authors":[{"name":"Moshe Szyf","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02666833700517556,"gpt":0.3297473750495071,"spread":0.3030790380443315,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001038196,0.001103632,0.001944623,0.001729424,0.0004819616,0.001310115,0.001376622,0.002009834,0.005248278],"category_scores_gemma":[0.0009529209,0.0004011637,0.0004619452,0.001628805,0.001089134,0.001536273,0.0009304322,0.003948406,0.002936854],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001165714,"about_ca_system_score_gemma":0.001032708,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001508556,"about_ca_topic_score_gemma":0.004787827,"domain_scores_codex":[0.9997031,0.00007178348,0.00002505249,0.00004840521,0.0001211554,0.00003041075],"domain_scores_gemma":[0.999725,0.0001203563,0.00002747547,0.00001565682,0.00007738017,0.00003403216],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001383446,0.00009636911,0.000148921,0.003184651,0.00006521032,0.0003376419,0.00005676041,0.0005686976,0.002966641,0.006621697,0.1155562,0.8702589],"study_design_scores_gemma":[0.0000276623,0.00004516877,0.0002238226,0.0004411417,0.00003628125,0.0007367565,0.00002619027,0.0001319929,0.0004899173,0.002485903,0.995346,0.000009124764],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00009344531,0.9947555,0.0004207538,0.001327101,0.001386964,0.000007733413,0.00001267029,0.00001700119,0.001978763],"genre_scores_gemma":[0.001304165,0.9900807,0.0006479414,0.0014121,0.001837912,0.0000174643,0.00003845644,0.000004987549,0.004656401],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.005248278,"threshold_uncertainty_score":0.01755726,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1973344697","doi":"10.1016/j.drup.2015.01.001","title":"RhoGTPases – A novel link between cytoskeleton organization and cisplatin resistance","year":2015,"lang":"en","type":"review","venue":"Drug Resistance Updates","topic":"Protein Kinase Regulation and GTPase Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":64,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"RhoC; RHOA; RHOB; Biology; Actin cytoskeleton; Cell biology; PAK1; CDC42; Cisplatin; GTPase; Cytoskeleton; Cancer research; Kinase; Signal transduction; Cell; Genetics","authors":[{"name":"Daphna Mokady","is_ca":true},{"name":"David Meiri","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02294902211328728,"gpt":0.2889868471376309,"spread":0.2660378250243436,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000411173,0.0005860282,0.0009940459,0.001022331,0.0001889738,0.0009129268,0.0006235386,0.001051206,0.002092767],"category_scores_gemma":[0.0005261412,0.0002097039,0.0003019042,0.0009844674,0.0004330815,0.001137168,0.0006409599,0.00179657,0.001232213],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004738751,"about_ca_system_score_gemma":0.0008055112,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005417115,"about_ca_topic_score_gemma":0.001466402,"domain_scores_codex":[0.9998864,0.00001404428,0.00001850584,0.00002270699,0.00004480908,0.00001355963],"domain_scores_gemma":[0.999848,0.00005872418,0.00002676641,0.000005514887,0.00004234365,0.00001865034],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001277106,0.00004803367,0.0002640059,0.007920248,0.00008029657,0.0003181314,0.00004423825,0.0003197413,0.004262044,0.005725458,0.04613652,0.9347536],"study_design_scores_gemma":[0.00002429846,0.00006700726,0.0009873864,0.001294614,0.0001293523,0.001330328,0.00004334648,0.0001620329,0.0009043239,0.002657056,0.9923805,0.00001988516],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001911177,0.9979805,0.0002073551,0.000667714,0.0003184896,0.000003048861,0.00002113741,0.00001015186,0.0006004671],"genre_scores_gemma":[0.001177729,0.9970542,0.0002309451,0.0003334606,0.0004454375,0.000004351005,0.00004518049,0.000001614792,0.0007070485],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.002092767,"threshold_uncertainty_score":0.007001042,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1976097884","doi":"10.1054/drup.2001.0190","title":"Lamivudine resistance in hepatitis B: mechanisms and clinical implications","year":2001,"lang":"en","type":"review","venue":"Drug Resistance Updates","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta","funders":"","keywords":"Lamivudine; Virology; Hepatitis B virus; Hepatitis B; Medicine; Nucleoside analogue; Seroconversion; Orthohepadnavirus; Immunology; Viral replication; Biology; Virus; Hepadnaviridae; Nucleoside; Genetics","authors":[{"name":"Karl P. Fischer","is_ca":true},{"name":"Klaus S. Gutfreund","is_ca":false},{"name":"D. Lorne Tyrrell","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04996537674272774,"gpt":0.37843679687203,"spread":0.3284714201293022,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001614121,0.000830498,0.002167401,0.002610525,0.0002526216,0.00121518,0.0008909912,0.001248802,0.002721565],"category_scores_gemma":[0.001992083,0.0002544013,0.0005515697,0.004208212,0.0004896286,0.00150505,0.0004818065,0.001117185,0.0009867699],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007438021,"about_ca_system_score_gemma":0.001755721,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001962634,"about_ca_topic_score_gemma":0.004899518,"domain_scores_codex":[0.999685,0.00008502999,0.0000661349,0.00004697917,0.00009768522,0.000019148],"domain_scores_gemma":[0.9987923,0.0007176108,0.0001758299,0.00002277934,0.0002402006,0.0000512699],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001477512,0.00004638159,0.0004072515,0.02081756,0.0001341741,0.0002215434,0.0000518665,0.0001399043,0.0007282954,0.0008501476,0.02101083,0.9554444],"study_design_scores_gemma":[0.0001212137,0.0002425826,0.003434939,0.0105818,0.0007843926,0.002401127,0.0002020059,0.0001024374,0.0004477327,0.001340038,0.9803105,0.00003111528],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00007773963,0.9993332,0.00003562987,0.000202086,0.00009051291,0.000002184289,0.000008061936,0.000002642186,0.0002478709],"genre_scores_gemma":[0.0003459073,0.9991198,0.0001172865,0.0001637916,0.0001061298,0.00000278467,0.00001002657,3.817998e-7,0.0001339903],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.002721565,"threshold_uncertainty_score":0.009104609,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2073200741","doi":"10.1016/j.drup.2012.03.003","title":"Immunotherapy: A useful strategy to help combat multidrug resistance","year":2012,"lang":"en","type":"review","venue":"Drug Resistance Updates","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":59,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"National Center for Research Resources; National Cancer Institute; National Institute on Aging; Fondation des Etoiles; Owens Foundation","keywords":"Immunotherapy; Cytotoxic T cell; Multiple drug resistance; Immune system; Cancer immunotherapy; Cancer; Immunology; Medicine; Biology; Drug resistance; Internal medicine; Microbiology","authors":[{"name":"Tyler J. Curiel","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03083223295627444,"gpt":0.2973822250195601,"spread":0.2665499920632857,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006897459,0.001265144,0.001578363,0.001751898,0.0002498354,0.001302069,0.0007192159,0.001816302,0.003212802],"category_scores_gemma":[0.0007995391,0.0002873361,0.000453027,0.001226064,0.000563235,0.001748808,0.0007208102,0.003843175,0.002251105],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006048474,"about_ca_system_score_gemma":0.0009056329,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005038857,"about_ca_topic_score_gemma":0.001502414,"domain_scores_codex":[0.9998099,0.00003719691,0.00002295222,0.00003264785,0.00007389858,0.00002334165],"domain_scores_gemma":[0.9996654,0.0001480861,0.00004488157,0.00001108218,0.00008680853,0.00004379167],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00008185259,0.00008846822,0.0001300675,0.005608026,0.00004418063,0.0001567297,0.0000219813,0.0002623078,0.003036539,0.002823583,0.06590058,0.9218457],"study_design_scores_gemma":[0.00005098185,0.0001236125,0.0005012939,0.001600506,0.00009130572,0.0009398292,0.00003223113,0.0001751593,0.0005884707,0.002178262,0.9937019,0.00001635389],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00009379094,0.9969715,0.0003040479,0.000858654,0.0007884575,0.000006312443,0.00001775559,0.00001381778,0.00094567],"genre_scores_gemma":[0.0007346148,0.9951048,0.0004916004,0.001065814,0.001219602,0.0000113861,0.00004872371,0.000003031881,0.001320408],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.003212802,"threshold_uncertainty_score":0.01074791,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2071822666","doi":"10.1054/drup.2000.0126","title":"Biochemical mechanisms involved in overcoming HIV resistance to nucleoside inhibitors of reverse transcriptase","year":2000,"lang":"en","type":"article","venue":"Drug Resistance Updates","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Medical Research Council; Health Canada","keywords":"Reverse transcriptase; Context (archaeology); Nucleoside; Drug resistance; Biology; Nucleoside Reverse Transcriptase Inhibitor; Enzyme; Drug; Human immunodeficiency virus (HIV); Virology; Amino acid; Genetics; Pharmacology; RNA; Biochemistry; Gene","authors":[{"name":"Matthias Götte","is_ca":false},{"name":"Mark A. Wainberg","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.006801987319243661,"gpt":0.2251592288602605,"spread":0.2183572415410168,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005799754,0.0005759826,0.000426056,0.0007436926,0.0005099688,0.001578878,0.0007101812,0.0009488577,0.002123873],"category_scores_gemma":[0.0005476251,0.0005190673,0.0003536668,0.0003079714,0.000775833,0.001717951,0.0003945844,0.00116621,0.0007334251],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008695928,"about_ca_system_score_gemma":0.0004724577,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005197973,"about_ca_topic_score_gemma":0.0008675593,"domain_scores_codex":[0.999741,0.00007225655,0.00002300274,0.00002562654,0.00007972362,0.00005834518],"domain_scores_gemma":[0.9997843,0.00006048853,0.00006508816,0.00001623716,0.0000536502,0.00002030123],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.001144116,0.0005596174,0.002086322,0.001784063,0.00007157181,0.001533106,0.0003829544,0.002643144,0.8192161,0.04449032,0.002303682,0.1237849],"study_design_scores_gemma":[0.0001923886,0.001601069,0.01235007,0.0001783641,0.000179238,0.006215852,0.0005989936,0.006405121,0.8707393,0.01748694,0.08398414,0.00006848315],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.5889886,0.3086189,0.02859128,0.0120203,0.00144059,0.0003663579,0.0004778696,0.0006687765,0.05882734],"genre_scores_gemma":[0.8737376,0.1030626,0.009829768,0.00083972,0.0005151874,0.00009940915,0.0003171808,0.00003265174,0.01156594],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002123873,"threshold_uncertainty_score":0.007105052,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1986171300","doi":"10.1016/j.drup.2004.06.004","title":"Prediction of drug sensitivity and drug resistance in cancer by transcriptional and proteomic profiling","year":2004,"lang":"en","type":"review","venue":"Drug Resistance Updates","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":38,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University Health Centre; Institute for Research in Immunology and Cancer; McGill University","funders":"National Cancer Institute; Cancer Research Society; Canadian Institutes of Health Research; Canadian Breast Cancer Research Alliance; Breast Cancer Alliance; Cancer Research Institute","keywords":"Drug resistance; Proteomics; Computational biology; Drug; Biology; Bioinformatics; Drug response; Cancer; Tumor microenvironment; Drug development; Medicine; Pharmacology; Gene; Genetics","authors":[{"name":"Moulay A. Alaoui‐Jamali","is_ca":true},{"name":"Ilaria Dupré","is_ca":true},{"name":"He Qiang","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01158990424308681,"gpt":0.2557509097724516,"spread":0.2441610055293648,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001858467,0.001343634,0.002586772,0.001575787,0.0001975213,0.001477818,0.001354121,0.001531069,0.001076244],"category_scores_gemma":[0.001585613,0.0003828586,0.0005657573,0.001962525,0.0006353459,0.001515801,0.0004629869,0.001965668,0.001691678],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006901793,"about_ca_system_score_gemma":0.0008232033,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001173665,"about_ca_topic_score_gemma":0.001445381,"domain_scores_codex":[0.9995846,0.0000567659,0.00003768622,0.0001070869,0.0001900193,0.0000238739],"domain_scores_gemma":[0.9989631,0.0005361757,0.0000886228,0.00004034805,0.0003180121,0.00005375122],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001512129,0.00008499627,0.001056391,0.002598511,0.00009792971,0.0001400893,0.00002433301,0.0006766423,0.007187813,0.001673591,0.01577506,0.9705335],"study_design_scores_gemma":[0.0001046466,0.0004780096,0.009911529,0.002243005,0.0006154194,0.004871299,0.0001570369,0.003029531,0.01820805,0.008960061,0.9513118,0.000109555],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0009095732,0.9910631,0.004905719,0.001018791,0.0003780472,0.00001344308,0.0001117763,0.0000747158,0.0015247],"genre_scores_gemma":[0.004061657,0.9872013,0.005508117,0.0006776078,0.0005320264,0.00002282007,0.0002257959,0.000009060463,0.001761514],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.002586772,"threshold_uncertainty_score":0.009828687,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2071538535","doi":"10.1016/j.drup.2009.02.001","title":"Mutational ‘hot-spots’ in mammalian, bacterial and protozoal dihydrofolate reductases associated with antifolate resistance: Sequence and structural comparison","year":2009,"lang":"en","type":"review","venue":"Drug Resistance Updates","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Université de Montréal","funders":"Canadian Institutes of Health Research","keywords":"Antifolate; Biology; Dihydrofolate reductase; Plasmodium falciparum; Genetics; Antimetabolite; Malaria; Gene; Immunology","authors":[{"name":"Jordan P. Volpato","is_ca":true},{"name":"Joelle N. Pelletier","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02741926110272969,"gpt":0.3193452072151339,"spread":0.2919259461124042,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003708161,0.0004749095,0.001149394,0.001325279,0.0001156448,0.0004491368,0.0006838327,0.0004810191,0.001380761],"category_scores_gemma":[0.0003920263,0.0001831349,0.0003639164,0.001517435,0.0002380988,0.0004573622,0.0002138127,0.0004565485,0.000619039],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003162264,"about_ca_system_score_gemma":0.0004258801,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009466575,"about_ca_topic_score_gemma":0.0017634,"domain_scores_codex":[0.9999003,0.00001095393,0.00001383742,0.00002488716,0.00003937158,0.00001059261],"domain_scores_gemma":[0.9998547,0.00004985819,0.00004512357,0.000004591377,0.0000369404,0.000008761629],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002053916,0.00005242231,0.0009582972,0.008708695,0.0001332508,0.0004644296,0.00006095727,0.0005139894,0.01841027,0.0009014534,0.006643726,0.9629471],"study_design_scores_gemma":[0.0001179052,0.0005988788,0.02079401,0.003425098,0.001179534,0.01361519,0.000233793,0.0007571483,0.02146957,0.002347285,0.9353794,0.00008218858],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.002912133,0.9955899,0.0003591169,0.0001273672,0.00005652043,0.000007511253,0.00006396663,0.0000174005,0.0008661166],"genre_scores_gemma":[0.007395769,0.9906398,0.0008619579,0.00012402,0.0000723503,0.000005945328,0.0001753025,0.000002904488,0.0007219136],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.001380761,"threshold_uncertainty_score":0.004619122,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1986396848","doi":"10.1016/j.drup.2008.04.001","title":"Progress and challenges in the identification of biomarkers for EGFR and VEGFR targeting anticancer agents","year":2008,"lang":"en","type":"review","venue":"Drug Resistance Updates","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre","funders":"Fondation de France; American Association for Cancer Research","keywords":"Medicine; Biomarker; Biomarker discovery; Trastuzumab; Imatinib; Drug; Clinical trial; Breast cancer; Druggability; Personalized medicine; Sunitinib; Oncology; Cancer; Pharmacology; Bioinformatics; Cancer research; Internal medicine; Biology; Proteomics","authors":[{"name":"Christophe Le Tourneau","is_ca":true},{"name":"Laura Vidal","is_ca":true},{"name":"Lillian L. Siu","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1392766723441191,"gpt":0.4201719401740726,"spread":0.2808952678299535,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003677162,0.0009995464,0.003107333,0.00224134,0.0003081579,0.002197026,0.001473483,0.002154917,0.002660464],"category_scores_gemma":[0.002981515,0.0004550517,0.00075468,0.002217637,0.0009402516,0.003743763,0.0009906122,0.003409727,0.002186169],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001040179,"about_ca_system_score_gemma":0.001676799,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001271373,"about_ca_topic_score_gemma":0.002756026,"domain_scores_codex":[0.9992949,0.0001566828,0.0001080347,0.0001069582,0.0002826329,0.00005071443],"domain_scores_gemma":[0.997606,0.001450413,0.0001872551,0.00005305212,0.0006085731,0.00009462001],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001128313,0.0000857054,0.0002934376,0.006619154,0.00006901239,0.0002585523,0.00006676871,0.0004099519,0.001999021,0.005090586,0.02879531,0.9561997],"study_design_scores_gemma":[0.00004993793,0.0001891244,0.0009052514,0.002486888,0.0001480479,0.001879301,0.0001179815,0.0004180997,0.00122071,0.003689669,0.9888647,0.00003029195],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001372098,0.9974167,0.0004568161,0.001145093,0.0002474338,0.000004415627,0.00001099825,0.00001033076,0.0005708976],"genre_scores_gemma":[0.0009124487,0.9961607,0.0009761177,0.0007520724,0.0004816737,0.000009258033,0.00002989856,0.000003191516,0.0006745807],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.003677162,"threshold_uncertainty_score":0.01944691,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1993572662","doi":"10.1054/drup.2002.0235","title":"HIV drug resistance and implications for the introduction of antiretroviral therapy in resource-poor countries","year":2001,"lang":"en","type":"article","venue":"Drug Resistance Updates","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Intensive care medicine; Drug resistance; Antiretroviral therapy; Developing country; Human immunodeficiency virus (HIV); Drug; Transmission (telecommunications); Resource (disambiguation); Immunology; Viral load; Pharmacology; Biology; Computer science","authors":[{"name":"Marco Petrella","is_ca":true},{"name":"Bluma Brenner","is_ca":true},{"name":"Hugues Loemba","is_ca":true},{"name":"Mark A. Wainberg","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.00856328859968757,"gpt":0.2516728424776016,"spread":0.243109553877914,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007428373,0.0002599843,0.0004379943,0.0009241892,0.001115776,0.003020542,0.0009037675,0.004045408,0.0117471],"category_scores_gemma":[0.03115033,0.0002547007,0.0004187372,0.00107738,0.001331671,0.002786948,0.001225356,0.002865823,0.0006523488],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001649004,"about_ca_system_score_gemma":0.00548477,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.02041321,"about_ca_topic_score_gemma":0.04570698,"domain_scores_codex":[0.9964444,0.002247009,0.000299685,0.00008876549,0.0006055016,0.000314701],"domain_scores_gemma":[0.980395,0.011246,0.001960617,0.0002840695,0.003535216,0.002578998],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0007854865,0.0003306019,0.04932406,0.001956136,0.00008018375,0.002272464,0.003856957,0.001280963,0.0005561783,0.01662342,0.5131017,0.4098318],"study_design_scores_gemma":[0.0002756287,0.0008410434,0.1801706,0.004508681,0.0003400724,0.002533812,0.02107156,0.001648529,0.0007935301,0.01304311,0.7746039,0.0001695083],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"review","genre_scores_codex":[0.03432897,0.05554859,0.0005275379,0.8849701,0.003969864,0.00003775702,0.0006824536,0.0001111662,0.01982361],"genre_scores_gemma":[0.6588921,0.1491508,0.004289549,0.1618626,0.01331243,0.0001228945,0.0006802728,0.0000585977,0.01163069],"genre_candidate":"review","genre_consensus":null,"teacher_disagreement_score":0.02041321,"threshold_uncertainty_score":0.0405888,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1971110677","doi":"10.1016/j.drup.2004.02.004","title":"New cancer therapeutics: target-specific in, cytotoxics out?","year":2004,"lang":"en","type":"article","venue":"Drug Resistance Updates","topic":"Microtubule and mitosis dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":22,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Pyrogenesis (Canada)","funders":"","keywords":"Cancer; Clinical trial; Biomarker; Medicine; Drug development; Proteomics; Targeted therapy; Biomarker discovery; Computational biology; Drug; Cancer research; Bioinformatics; Pharmacology; Biology; Internal medicine","authors":[{"name":"Henk J. Broxterman","is_ca":false},{"name":"N H Georgopapadakou","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.008700666978959477,"gpt":0.2475809144283475,"spread":0.238880247449388,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004132567,0.0007036609,0.001873772,0.0007174922,0.0007862572,0.00296746,0.001129219,0.002752603,0.009456234],"category_scores_gemma":[0.003498666,0.0004627997,0.0006845066,0.0005973473,0.001593697,0.007510418,0.001003205,0.006174984,0.002435525],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001181677,"about_ca_system_score_gemma":0.001111076,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005955078,"about_ca_topic_score_gemma":0.002640838,"domain_scores_codex":[0.9992174,0.0001821956,0.0001147336,0.0001104467,0.0002714758,0.0001037489],"domain_scores_gemma":[0.9978127,0.0009438918,0.0001791411,0.0001641905,0.0007002331,0.0001997462],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0005550699,0.0002852354,0.001093628,0.002414416,0.000141715,0.0004881085,0.0003349734,0.0006508293,0.01764904,0.03249652,0.1408445,0.8030458],"study_design_scores_gemma":[0.0001821276,0.0007953704,0.00123292,0.0005329732,0.0002255447,0.001991739,0.00047814,0.0009225595,0.007268298,0.02636392,0.95994,0.00006655101],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"commentary","genre_scores_codex":[0.01870415,0.7020344,0.01605912,0.2140607,0.01598378,0.0001048338,0.000292439,0.0007719156,0.0319887],"genre_scores_gemma":[0.1172062,0.6685441,0.02036533,0.1260726,0.02876177,0.0001472242,0.0004312863,0.0003356113,0.03813595],"genre_candidate":"commentary","genre_consensus":null,"teacher_disagreement_score":0.009456234,"threshold_uncertainty_score":0.03163427,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1987122879","doi":"10.1016/s1368-7646(03)00024-4","title":"The interface between ErbB and non-ErbB receptors in tumor invasion: clinical implications and opportunities for target discovery","year":2003,"lang":"en","type":"review","venue":"Drug Resistance Updates","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University","funders":"National Cancer Institute; Breast Cancer Society of Canada; Cancer Research Society","keywords":"ErbB; Biology; Receptor tyrosine kinase; Receptor; Drug discovery; Signal transduction; Cancer research; Context (archaeology); Cell signaling; Bioinformatics; Cell biology; Genetics","authors":[{"name":"Moulay A. Alaoui‐Jamali","is_ca":true},{"name":"He Qiang","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1794879031040422,"gpt":0.4597632419439453,"spread":0.2802753388399031,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001214732,0.0009599724,0.001990723,0.001666289,0.0003131106,0.0016596,0.001010033,0.001857905,0.002480669],"category_scores_gemma":[0.0008593181,0.0003444062,0.0005329395,0.002263602,0.0008086606,0.002510792,0.0006046952,0.002543171,0.00168033],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001079924,"about_ca_system_score_gemma":0.00135959,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001584614,"about_ca_topic_score_gemma":0.004261848,"domain_scores_codex":[0.9997583,0.00005065204,0.00003099618,0.00004375299,0.00009256027,0.00002365351],"domain_scores_gemma":[0.9996142,0.0002132431,0.00003619941,0.00001014475,0.00009763825,0.00002847748],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002257408,0.00009800812,0.0002325968,0.008433335,0.00007789677,0.0005328307,0.0001052709,0.0004008949,0.003153952,0.005258324,0.04970132,0.9317799],"study_design_scores_gemma":[0.00005099788,0.0001194619,0.000610081,0.001624407,0.00009964153,0.001609067,0.0001181011,0.0001191912,0.0005977947,0.002406685,0.9926255,0.00001901614],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001154488,0.9982865,0.0001603753,0.0004919585,0.0002922211,0.000002956911,0.000008563615,0.000004839647,0.0006370032],"genre_scores_gemma":[0.0005672493,0.9975703,0.0002894896,0.0004034848,0.000287811,0.000005142615,0.00001654682,0.000001157399,0.0008587971],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.002480669,"threshold_uncertainty_score":0.008298635,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1969152525","doi":"10.1016/j.drup.2004.06.001","title":"The emergence of HIV resistance and new antiretrovirals: are we winning?","year":2004,"lang":"en","type":"review","venue":"Drug Resistance Updates","topic":"HIV Research and Treatment","field":"Immunology and Microbiology","cited_by":9,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Jewish General Hospital; McGill University","funders":"","keywords":"Human immunodeficiency virus (HIV); Resistance (ecology); Perspective (graphical); Antiretroviral therapy; Virology; Medicine; Biology; Viral load; Computer science; Artificial intelligence; Ecology","authors":[{"name":"Mark A. Wainberg","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03205993354073074,"gpt":0.3110628451451023,"spread":0.2790029116043716,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002476108,0.001307745,0.003124684,0.001540535,0.0006778167,0.002888411,0.001483974,0.005003935,0.006108579],"category_scores_gemma":[0.003537948,0.0004162694,0.0006046019,0.002164246,0.001448206,0.005571899,0.0009012067,0.005550112,0.003796147],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00140461,"about_ca_system_score_gemma":0.00285971,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0024532,"about_ca_topic_score_gemma":0.006621283,"domain_scores_codex":[0.9992989,0.0001911216,0.00007462998,0.00007437426,0.0002841193,0.00007686451],"domain_scores_gemma":[0.9977863,0.001079243,0.0001768639,0.00005352063,0.0006356702,0.000268419],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001455373,0.00006530606,0.000265789,0.004452411,0.00005554295,0.0002691819,0.00007545691,0.0001489807,0.000419253,0.003420535,0.2352392,0.7554427],"study_design_scores_gemma":[0.00003020874,0.00006138071,0.0004539549,0.001624107,0.00005348576,0.0008860399,0.0001128847,0.00004433678,0.00005855391,0.001750028,0.9949127,0.00001222384],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0000514138,0.9920466,0.00009737346,0.004447789,0.002509014,0.000002452879,0.000007721538,0.00001066208,0.0008269927],"genre_scores_gemma":[0.0004719477,0.9910964,0.0002732618,0.003343,0.003472681,0.000005738002,0.00001939701,0.000002527854,0.001315089],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.006108579,"threshold_uncertainty_score":0.02043521,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4407599227","doi":"10.1016/j.drup.2025.101213","title":"Sanfetrinem, an oral β-lactam antibiotic repurposed for the treatment of tuberculosis","year":2025,"lang":"en","type":"article","venue":"Drug Resistance Updates","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":8,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia","funders":"H2020 Marie Skłodowska-Curie Actions; FP7 People: Marie-Curie Actions; National Institutes of Health; Universidad de Zaragoza; National Institute of Allergy and Infectious Diseases; Division of Intramural Research, National Institute of Allergy and Infectious Diseases; European Commission; Horizon 2020 Framework Programme","keywords":"Antibiotics; Medicine; Lactam; Tuberculosis; Microbiology; Chemistry; Biology; Pathology","authors":[{"name":"Santiago Ramón‐García","is_ca":false},{"name":"Rubén González del Río","is_ca":false},{"name":"María Pilar Arenaz-Callao","is_ca":false},{"name":"Helena I. Boshoff","is_ca":false},{"name":"Joaquín Rullás","is_ca":false},{"name":"Sara Anca","is_ca":false},{"name":"Mónica Cacho Izquierdo","is_ca":false},{"name":"Esther Porras de Francisco","is_ca":false},{"name":"Ángel Santos-Villarejo","is_ca":false},{"name":"Alfonso Mendoza-Losana","is_ca":false},{"name":"Santiago Ferrer","is_ca":false},{"name":"Charles J. Thompson","is_ca":true},{"name":"David Barros-Aguirre","is_ca":false},{"name":"Robert H. Bates","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0657759882485501,"gpt":0.4339001372049818,"spread":0.3681241489564316,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009669449,0.0002967994,0.0003249531,0.0003175751,0.0001790908,0.0002466151,0.0002460737,0.0003105356,0.001820053],"category_scores_gemma":[0.0001397185,0.00009426447,0.00024933,0.0001942932,0.0001947054,0.0001878556,0.0002334234,0.0004941139,0.0005187451],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001387518,"about_ca_system_score_gemma":0.0002079136,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002909226,"about_ca_topic_score_gemma":0.0006605309,"domain_scores_codex":[0.9999224,0.0000123561,0.000006557133,0.00001466288,0.00003208577,0.0000119903],"domain_scores_gemma":[0.9999558,0.00000789045,0.00001533081,0.000003373984,0.000007567561,0.00001012665],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0009548524,0.0004754016,0.001545734,0.001067667,0.00004096784,0.000848194,0.0000542523,0.0002613669,0.8280075,0.0004510937,0.00164729,0.1646457],"study_design_scores_gemma":[0.0005032494,0.01098606,0.01258002,0.0002521382,0.0002110564,0.007384287,0.00009789169,0.001278353,0.8295302,0.0002662843,0.1368591,0.00005125141],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"review","genre_scores_codex":[0.7547964,0.2135495,0.00809202,0.0009820522,0.0006881192,0.000444331,0.00108309,0.0004449359,0.01991941],"genre_scores_gemma":[0.9171098,0.06642874,0.006888859,0.0006225964,0.0002770834,0.0001126302,0.001019746,0.00002727708,0.007513337],"genre_candidate":"review","genre_consensus":null,"teacher_disagreement_score":0.001820053,"threshold_uncertainty_score":0.006088674,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2800029404","doi":"10.1016/j.drup.2018.04.001","title":"Corrigendum to “Hepatitis C virus drug resistance associated substitutions and their clinical relevance: Update 2018” [Drug Resist. Updates 37 (March) (2018) 17–39]","year":2018,"lang":"en","type":"erratum","venue":"Drug Resistance Updates","topic":"Hepatitis C virus research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"St. Paul's Hospital","funders":"","keywords":"Drug; Virology; Drug resistance; Medicine; Relevance (law); Hepatitis C virus; Virus; Biology; Pharmacology; Genetics; Political science","authors":[{"name":"M.C. Sorbo","is_ca":false},{"name":"Valeria Cento","is_ca":false},{"name":"Velia Chiara Di Maio","is_ca":false},{"name":"A Howe","is_ca":true},{"name":"Féderico García","is_ca":false},{"name":"Carlo Federico Perno","is_ca":false},{"name":"Francesca Ceccherini‐Silberstein","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03217018304041553,"gpt":0.3204840388718854,"spread":0.2883138558314698,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002431531,0.001932831,0.002346196,0.003532521,0.002473625,0.003849179,0.002587076,0.008518272,0.1352317],"category_scores_gemma":[0.03284698,0.001078715,0.002174175,0.002296551,0.001696118,0.002334872,0.002058878,0.007904285,0.1180968],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003324156,"about_ca_system_score_gemma":0.005642971,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01540294,"about_ca_topic_score_gemma":0.02978368,"domain_scores_codex":[0.9962022,0.0005226973,0.0006309089,0.0003728449,0.001829711,0.0004416094],"domain_scores_gemma":[0.9772105,0.004851814,0.001767791,0.0007628124,0.0139226,0.001484539],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00001044601,0.000006239305,0.0000253176,0.00005164125,0.000002600148,0.00006418729,0.000003391359,0.000009886567,0.00001139232,0.0001032498,0.9959232,0.003788456],"study_design_scores_gemma":[0.00004083595,0.00002940535,0.0006442196,0.0003736674,0.0000242775,0.0002057855,0.00003278927,0.00009288951,0.0001211553,0.0005354524,0.9978774,0.00002208201],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"editorial","genre_gemma":"other","genre_scores_codex":[0.00006836414,0.002408915,0.00020341,0.08403751,0.900337,0.00004982527,0.001035519,0.0003368692,0.01152268],"genre_scores_gemma":[0.003339297,0.01503592,0.001578784,0.2063234,0.415844,0.0002171989,0.00377735,0.0005364257,0.3533475],"genre_candidate":"other","genre_consensus":null,"teacher_disagreement_score":0.1352317,"threshold_uncertainty_score":0.452395,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W7117586634","doi":"10.1016/j.drup.2025.101349","title":"AMPKα2 attenuates doxorubicin induced ferroptosis by promoting NCOA4 degradation in triple negative breast cancer","year":2025,"lang":"en","type":"article","venue":"Drug Resistance Updates","topic":"Ferroptosis and cancer prognosis","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Calgary","funders":"Medical and Health Research Project of Zhejiang Province; Natural Science Foundation of Ningbo; Higher Education Discipline Innovation Project; Natural Science Foundation of Zhejiang Province; National Natural Science Foundation of China","keywords":"Triple-negative breast cancer; Doxorubicin; Degradation (telecommunications); Breast cancer; Cancer; Apoptosis","authors":[{"name":"Xinjun Liu","is_ca":false},{"name":"Zizhen Si","is_ca":false},{"name":"Linbo Li","is_ca":false},{"name":"Miao Zhou","is_ca":false},{"name":"Ki-Young Lee","is_ca":true},{"name":"Xidi Wang","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01015032993666657,"gpt":0.2806916703124635,"spread":0.2705413403757969,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001753604,0.0001961557,0.0002624985,0.0001574873,0.000127653,0.0003011867,0.0001828228,0.0002167636,0.002745857],"category_scores_gemma":[0.0001660508,0.00009722159,0.0001708971,0.000101823,0.0001211894,0.0001755431,0.0001385995,0.0006881403,0.0004315616],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002576077,"about_ca_system_score_gemma":0.00021934,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004351427,"about_ca_topic_score_gemma":0.001526978,"domain_scores_codex":[0.9999413,0.00001125603,0.000005379992,0.000009127706,0.00001708674,0.0000158131],"domain_scores_gemma":[0.9999434,0.000008415625,0.00001528558,0.000005642456,0.00001483337,0.00001257709],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.005983502,0.0006224579,0.003336173,0.001028555,0.0002286469,0.0002906224,0.00008505553,0.0003696762,0.809463,0.000934747,0.01512013,0.1625375],"study_design_scores_gemma":[0.001425151,0.005151254,0.04381285,0.0002611021,0.0006594768,0.002253653,0.0003571233,0.002749891,0.7175416,0.001189526,0.2245435,0.00005489778],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8588189,0.1173069,0.003850128,0.006897563,0.00178659,0.00007684361,0.000942793,0.0004534154,0.009866775],"genre_scores_gemma":[0.950584,0.03333208,0.002351987,0.001024981,0.0003755305,0.00005331295,0.000949498,0.00004443259,0.01128411],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002745857,"threshold_uncertainty_score":0.009185851,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4410266122","doi":"10.1016/j.drup.2025.101251","title":"MicroRNA-mediated PTEN downregulation as a novel non-genetic mechanism of acquired resistance to PI3Kα inhibitors of head & neck squamous cell carcinoma","year":2025,"lang":"en","type":"article","venue":"Drug Resistance Updates","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Western University; Princess Margaret Cancer Centre; University Health Network","funders":"Associazione Italiana per la Ricerca sul Cancro; Ministero della Salute; Fondazione AIRC per la ricerca sul cancro ETS","keywords":"PTEN; Downregulation and upregulation; Head and neck squamous-cell carcinoma; Cancer research; microRNA; PI3K/AKT/mTOR pathway; Head and neck; Mechanism (biology); Medicine; Head and neck cancer; Basal cell; Oncology; Internal medicine; Biology; Cancer; Signal transduction; Gene; Genetics; Surgery","authors":[{"name":"Claudio Pulito","is_ca":false},{"name":"Sebastiano Vaccarella","is_ca":false},{"name":"Alina Catalina Palcau","is_ca":false},{"name":"Federica Ganci","is_ca":false},{"name":"Renata Brandi","is_ca":false},{"name":"Carlotta Frascolla","is_ca":false},{"name":"Andrea Sacconi","is_ca":false},{"name":"Valeria Canu","is_ca":false},{"name":"Anna Benedetti","is_ca":false},{"name":"Valentina De Pascale","is_ca":false},{"name":"Sara Donzelli","is_ca":false},{"name":"Anne-Sophie Fisch","is_ca":false},{"name":"Valentina Manciocco","is_ca":false},{"name":"Renato Covello","is_ca":false},{"name":"Fulvia Pimpinelli","is_ca":false},{"name":"Aldo Morrone","is_ca":false},{"name":"Raul Pellini","is_ca":false},{"name":"Paola Muti","is_ca":false},{"name":"Jalna Meens","is_ca":true},{"name":"Christina Karamboulas","is_ca":true},{"name":"Anthony C. Nichols","is_ca":true},{"name":"Sabrina Strano","is_ca":false},{"name":"Konrad Klinghammer","is_ca":false},{"name":"Ingeborg Tinhofer","is_ca":false},{"name":"Laurie Ailles","is_ca":true},{"name":"Giulia Fontemaggi","is_ca":false},{"name":"Giovanni Blandino","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.005825822523603009,"gpt":0.2379051853537052,"spread":0.2320793628301022,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002471315,0.0002806318,0.0002106116,0.0002826985,0.0001751945,0.0007236345,0.0002971732,0.00036456,0.001277889],"category_scores_gemma":[0.0002097855,0.0001555937,0.0003301449,0.0001951357,0.0002666011,0.0002839107,0.0002160163,0.0004337527,0.000278037],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004425044,"about_ca_system_score_gemma":0.0003053364,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003618475,"about_ca_topic_score_gemma":0.0006535638,"domain_scores_codex":[0.9998497,0.00001587184,0.00001169961,0.0000217779,0.00007256419,0.00002838607],"domain_scores_gemma":[0.9999452,0.00001018914,0.00001805362,0.000007927279,0.00001079582,0.000007890855],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0001951267,0.00008290916,0.004550026,0.0001417342,0.00004813971,0.002780344,0.00005765295,0.0002677512,0.9658554,0.002525211,0.0009594999,0.02253614],"study_design_scores_gemma":[0.00008173744,0.0007042315,0.06851966,0.00003018039,0.0002510838,0.01519992,0.0001758558,0.005339898,0.8793469,0.001029389,0.02928914,0.00003199492],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.969015,0.01171988,0.006024989,0.001037722,0.0001911415,0.00007745918,0.0003624238,0.0003654872,0.01120586],"genre_scores_gemma":[0.9928715,0.00327447,0.001087424,0.0001534212,0.00003512568,0.00002052999,0.000183799,0.00001585659,0.002358],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001277889,"threshold_uncertainty_score":0.004274964,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4413147816","doi":"10.1016/j.drup.2025.101291","title":"Defining homologous recombination deficiency status in pancreatic ductal adenocarcinoma: Clinical implications for evaluating response to platinum chemotherapy","year":2025,"lang":"en","type":"article","venue":"Drug Resistance Updates","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"MD Precision (Canada)","funders":"Science and Technology Planning Project of Guangdong Province; Guangzhou Science and Technology Program key projects; National Natural Science Foundation of China","keywords":"Pancreatic ductal adenocarcinoma; Homologous recombination; Chemotherapy; Medicine; Oncology; Adenocarcinoma; Internal medicine; Pancreatic cancer; Biology; Genetics; Cancer; Gene","authors":[{"name":"Yanxia Wang","is_ca":false},{"name":"Fan-Cheng Kong","is_ca":true},{"name":"Xiaohua Situ","is_ca":false},{"name":"Tiantian Yang","is_ca":false},{"name":"T. Sun","is_ca":true},{"name":"Zhongpeng Xie","is_ca":false},{"name":"Wang Pingling","is_ca":false},{"name":"Yu Chen","is_ca":false},{"name":"Neng Jiang","is_ca":false},{"name":"Yu Dong","is_ca":true},{"name":"Zhaofan Luo","is_ca":false},{"name":"Zunfu Ke","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03174208239471961,"gpt":0.4030723445521907,"spread":0.3713302621574711,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009371713,0.0001770531,0.0003265936,0.0009849661,0.0001635729,0.0005543784,0.0002024531,0.0002355296,0.000466476],"category_scores_gemma":[0.002239724,0.00009058532,0.0001982451,0.0007988273,0.0002598213,0.0002531359,0.0003617481,0.0002320837,0.0001338147],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001333134,"about_ca_system_score_gemma":0.0001266654,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003567121,"about_ca_topic_score_gemma":0.0004516958,"domain_scores_codex":[0.9995075,0.0001594657,0.0001075841,0.00008562442,0.00009439764,0.00004535923],"domain_scores_gemma":[0.9985161,0.000527369,0.0005488922,0.00008835855,0.0001502431,0.0001690232],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0001110722,0.000008080331,0.9966387,0.000007183143,0.00001346837,0.00006386064,0.00001796426,0.00003596696,0.0006816382,0.000005048308,0.00001285352,0.002404165],"study_design_scores_gemma":[0.000003587597,0.0001284037,0.9974826,0.000008488583,0.00003510346,0.001126289,0.000126811,0.0003547201,0.0004929596,0.00002963468,0.0002087652,0.00000264436],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.998414,0.0009016877,0.0002204452,0.00002491772,0.000003335876,0.000005617119,0.00008850098,0.000003299805,0.0003381934],"genre_scores_gemma":[0.9995547,0.0001585803,0.0001626738,0.000009776758,0.000004920819,0.000002750192,0.00006828438,8.792087e-7,0.00003756868],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0009849661,"threshold_uncertainty_score":0.004956305,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4415641574","doi":"10.1016/j.drup.2025.101319","title":"ZBP1 antagonizes MRE11-mediated DNA end resection and confers synthetic lethality to PARP inhibition in ovarian cancer","year":2025,"lang":"en","type":"article","venue":"Drug Resistance Updates","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université de Sherbrooke","funders":"National Key Research and Development Program of China; National Natural Science Foundation of China; Foundation for Innovative Research Groups of the National Natural Science Foundation of China; Foundation for Innovative Research Groups of Hubei Province of China; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; Breast Cancer Research Foundation","keywords":"Synthetic lethality; Poly ADP ribose polymerase; PARP inhibitor; Ovarian cancer; DNA damage; DNA repair; Olaparib; Programmed cell death","authors":[{"name":"Shen-Nan Shi","is_ca":false},{"name":"Qiuyang Xu","is_ca":false},{"name":"Zhiqi Liao","is_ca":false},{"name":"Wenjian Gong","is_ca":false},{"name":"Yilin Cui","is_ca":false},{"name":"Jiahao Liu","is_ca":false},{"name":"Xiaofei Jiao","is_ca":false},{"name":"Yijie Wu","is_ca":false},{"name":"Mengshi Luo","is_ca":false},{"name":"Linghui Wang","is_ca":false},{"name":"Yuanjia Wen","is_ca":false},{"name":"Wen Pan","is_ca":false},{"name":"Xuejiao Zhao","is_ca":false},{"name":"Marilyne Labrie","is_ca":true},{"name":"Zhiyong Ding","is_ca":false},{"name":"Gordon B. Mills","is_ca":false},{"name":"Ding Ma","is_ca":false},{"name":"Guang‐Nian Zhao","is_ca":false},{"name":"Qinglei Gao","is_ca":false},{"name":"Yong Fang","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01111696408568013,"gpt":0.3024694275648923,"spread":0.2913524634792121,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003290212,0.000391939,0.0003809707,0.000417266,0.0002369947,0.0006294769,0.0004737263,0.000420574,0.003637078],"category_scores_gemma":[0.000265294,0.0002835225,0.0002963445,0.0003094058,0.0003597733,0.0002788885,0.0003588182,0.001519113,0.000905802],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005784329,"about_ca_system_score_gemma":0.0004812098,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001462296,"about_ca_topic_score_gemma":0.003422532,"domain_scores_codex":[0.9997603,0.00003295271,0.00001901534,0.00003350546,0.00008137982,0.00007272508],"domain_scores_gemma":[0.9998871,0.00001986453,0.00002903564,0.00001751336,0.00001875137,0.00002771897],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0007952427,0.0002402338,0.001107045,0.000166978,0.0000710192,0.0001443861,0.00003489157,0.0007790569,0.9686257,0.001069498,0.002332637,0.02463331],"study_design_scores_gemma":[0.0001216684,0.0009785545,0.007900079,0.00001787991,0.00005074186,0.0006666501,0.00009284863,0.001443645,0.9637162,0.0001695966,0.024825,0.00001704535],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.958111,0.01467818,0.007700524,0.002324746,0.0003946473,0.0001156304,0.002191537,0.0008451103,0.01363863],"genre_scores_gemma":[0.9817479,0.006733481,0.001955119,0.0002703987,0.00002570104,0.0000401557,0.002066729,0.00005736059,0.007103139],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003637078,"threshold_uncertainty_score":0.01216722,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}